Search results for "antibody"
Article
Impurity Testing of Biologic Drug Products
This is true even when considering different monoclonal antibody therapeutics. Consequently, while similar strategies may be used for different protein therapeutics, true ‘toolbox’ approaches/platform…
Article
3rd BioProcessing Asia Preview: Q&A with John Curling
… are perhaps two topics at the opposite ends of the manufacturing scale: development of high-volume antibody processes and then cell based therapies.
As the monoclonal antibody industry moves to…
Article
Safety Drives Innovation in Animal-Component-Free Cell-Culture Media Technology
Advances in cell culture media technology have helped achieve safer biologics.
By Tom Fletcher, Holden Harris
Regulatory expectations for cell-culture-based biologics production processes ch…
Article
Detecting Protein Aggregates and Evaluating their Immunogenicity
Mar 01, 2015
By Randi Hernandez
BioPharm International
Volume 3, Issue 28
Aggregation in biopharmaceuticals remains a major concern and threatens the stability of a product. Protein …
Article
The Bullish Outlook for Biosimilars
In 2013, the EU’s decision to formally approve both Remsima (infliximab) and Inflectra (infliximab)--the world’s first monoclonal antibody (mAb) biosimilars by Celltrion and Hospira, respectively--rep…
Article
What Drove Biopharma Development in 2014?
In addition to developing quality biopharmaceuticals, manufacturers continue to create innovative medicines for treating various diseases, thus driving the trend of next-generation antibody-based ther…
Article
Optimizing Resin Performance with Disposable Chromatography Solutions
Shawn Knol/GETTY IMAGES
By: Randi Hernandez
BioPharm International, spoke to Fredrik Lundström, product manager, Cytiva; Jonathan Royce, bioprocess senior product manager of antibody affinity …
Article
Biopharma Manufacturers Respond to Ebola Crisis
DOD is supporting Phase I trials at the Walter Reed Army Institute of Research to determine safety and antibody response, and additional studies will test different dosing schedules. NewLink has suffi…
Article
Predicting Progress in Protein Aggregation
Lonza’s database currently includes information on the aggregation behavior and properties of more than 1000 individual antibody molecules.
Potential protein-based drug candidates are screened a…
Article
Recap: Chromatography + filtration virtual summit 2024
Don’t worry – here are the highlights and session recordings from the event on optimizing purification and filtration for mAbs, antibody variants, recombinant proteins, and gene therapy.
See highli…